139 related articles for article (PubMed ID: 17988456)
1. Rapid quantification of urinary oxycodone and oxymorphone using fast gas chromatography-mass spectrometry.
McKinley S; Snyder JJ; Welsh E; Kazarian CM; Jamerson MH; Klette KL
J Anal Toxicol; 2007 Oct; 31(8):434-41. PubMed ID: 17988456
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the DRI oxycodone immunoassay for the detection of oxycodone in urine.
Backer RC; Monforte JR; Poklis A
J Anal Toxicol; 2005 Oct; 29(7):675-7. PubMed ID: 16419399
[TBL] [Abstract][Full Text] [Related]
3. Determination of oxycodone and its major metabolites noroxycodone and oxymorphone by ultra-high-performance liquid chromatography tandem mass spectrometry in plasma and urine: application to real cases.
Pantano F; Brauneis S; Forneris A; Pacifici R; Marinelli E; Kyriakou C; Pichini S; Busardò FP
Clin Chem Lab Med; 2017 Aug; 55(9):1324-1331. PubMed ID: 28080998
[TBL] [Abstract][Full Text] [Related]
4. GC-MS confirmation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in urine.
Meatherall R
J Anal Toxicol; 1999; 23(3):177-86. PubMed ID: 10369327
[TBL] [Abstract][Full Text] [Related]
5. GC-MS quantitation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in blood.
Meatherall R
J Anal Toxicol; 2005; 29(5):301-8. PubMed ID: 16105253
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous identification and quantitation of codeine, morphine, hydrocodone, and hydromorphone in urine as trimethylsilyl and oxime derivatives by gas chromatography-mass spectrometry.
Broussard LA; Presley LC; Pittman T; Clouette R; Wimbish GH
Clin Chem; 1997 Jun; 43(6 Pt 1):1029-32. PubMed ID: 9191557
[TBL] [Abstract][Full Text] [Related]
7. Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry.
Smith ML; Hughes RO; Levine B; Dickerson S; Darwin WD; Cone EJ
J Anal Toxicol; 1995; 19(1):18-26. PubMed ID: 7536861
[TBL] [Abstract][Full Text] [Related]
8. Comparison of an automated and point-of-care immunoassay to GC-MS for urine oxycodone testing in the clinical laboratory.
Haller CA; Stone J; Burke V; Branch J; Chen K; Gross S
J Anal Toxicol; 2006 Mar; 30(2):106-11. PubMed ID: 16620541
[TBL] [Abstract][Full Text] [Related]
9. Resolution of an apparent hook effect in Roche partner DRI oxycodone immunoassay.
Colón-Franco JM; Cox ET; Crosby DB; Dawling S
J Anal Toxicol; 2013; 37(6):376-81. PubMed ID: 23711948
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the usefulness of an oxycodone immunoassay in combination with a traditional opiate immunoassay for the screening of opiates in urine.
Gingras M; Laberge MH; Lefebvre M
J Anal Toxicol; 2010 Mar; 34(2):78-83. PubMed ID: 20223099
[TBL] [Abstract][Full Text] [Related]
11. A solid phase extraction technique for the isolation and identification of opiates in urine.
Huang W; Andollo W; Hearn WL
J Anal Toxicol; 1992; 16(5):307-10. PubMed ID: 1284136
[TBL] [Abstract][Full Text] [Related]
12. Observations on the urine metabolic ratio of oxymorphone to oxycodone in pain patients.
Yee DA; Best BM; Atayee RS; Pesce AJ
J Anal Toxicol; 2012 May; 36(4):232-8. PubMed ID: 22511697
[TBL] [Abstract][Full Text] [Related]
13. Determination of oxycodone, noroxycodone and oxymorphone by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry in human matrices: in vivo and in vitro applications.
Fang WB; Lofwall MR; Walsh SL; Moody DE
J Anal Toxicol; 2013; 37(6):337-44. PubMed ID: 23743505
[TBL] [Abstract][Full Text] [Related]
14. Prescription Opioids. V. Metabolism and Excretion of Oxymorphone in Urine Following Controlled Single Dose Administration.
DePriest AZ; Heltsley R; Black DL; Mitchell JM; LoDico C; Flegel R; Cone EJ
J Anal Toxicol; 2016 Oct; 40(8):566-574. PubMed ID: 27405370
[TBL] [Abstract][Full Text] [Related]
15. Identification of oxymorphone as decomposition product of the permitted drug methylnaltrexone.
Sobolevsky T; Kucherova Y; Ahrens B
Drug Test Anal; 2018 May; 10(5):892-895. PubMed ID: 29314653
[No Abstract] [Full Text] [Related]
16. Distinction among eight opiate drugs in urine by gas chromatography-mass spectrometry.
Nowatzke W; Zeng J; Saunders A; Bohrer A; Koenig J; Turk J
J Pharm Biomed Anal; 1999 Sep; 20(5):815-28. PubMed ID: 10701990
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of oxycodone in blood and urine using gas chromatography-mass spectrometry (GC-MS).
Goldberger BA; Chronister CW; Merves ML
Methods Mol Biol; 2010; 603():453-60. PubMed ID: 20077097
[TBL] [Abstract][Full Text] [Related]
18. Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometry.
Neuvonen M; Neuvonen PJ
Ther Drug Monit; 2008 Jun; 30(3):333-40. PubMed ID: 18520605
[TBL] [Abstract][Full Text] [Related]
19. Prescription opioids. I. Metabolism and excretion patterns of oxycodone in urine following controlled single dose administration.
Cone EJ; Heltsley R; Black DL; Mitchell JM; Lodico CP; Flegel RR
J Anal Toxicol; 2013 Jun; 37(5):255-64. PubMed ID: 23609023
[TBL] [Abstract][Full Text] [Related]
20. Observations of urinary oxycodone and metabolite distributions in pain patients.
Elder NM; Atayee RS; Best BM; Ma JD
J Anal Toxicol; 2014 Apr; 38(3):129-34. PubMed ID: 24523296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
